Aptevo Therapeutics Inc. Current Federal Tax Expense (Benefit)
Aptevo Therapeutics Inc. (APVO) reported Current Federal Tax Expense (Benefit) of -$12.05 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2019-03-18
- Aptevo Therapeutics Inc. current federal tax expense (benefit) for fiscal 2017 was -$12.05M.
- Aptevo Therapeutics Inc. current federal tax expense (benefit) for fiscal 2016 was -$4.25M.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2017-12-31 | -$12.05M 10-K · filed 2019-03-18 |
| 2016-12-31 | -$4.25M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |